GlassScriptPhysician profile
Aisha Akhtar
NPI 1316314909
$2,994.14
in general payments reported to CMS, 2019-2025
13 companies · $367 in 2025
The $367 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $255 · 2022: $968 · 2023: $640 · 2024: $764 · 2025: $367.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,306 · Travel and Lodging: $465.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,306.28 |
| Travel and Lodging | $464.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thd America, INC. | $619.20 | 2022 | |
| Intuitive Surgical, INC. | $599.20 | 2022-2023 | Da Vinci Surgical System |
| Axonics, INC. | $547.12 | 2022-2024 | Axonics, Bulkamid |
| Davol INC. | $263.98 | 2022-2024 | Phasix Mesh |
| Teleflex LLC | $256.64 | 2024-2025 | Solesta |
| Stryker Corporation | $254.99 | 2021 | |
| Boston Scientific Corporation | $207.46 | 2025 | Axonics, Bulkamid |
| Medtronic, INC. | $112.29 | 2023-2024 | Interstim |
| Aroa Biosurgery Incorporated | $36.09 | 2023 | |
| Baxter Healthcare | $31.69 | 2025 | Perclot |
| Takeda Pharmaceuticals U.S.A., INC. | $30.25 | 2023 | Gattex |
| Vertex Pharmaceuticals Incorporated | $21.30 | 2025 | |
| Braintree Laboratories, INC. | $13.93 | 2025 | Suflave, Sutab |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aisha Akhtar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.